These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7519142

  • 21. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR, Jones D, Reba RC, Mann U, Coppola R, Gibson R, Gorey J, Braun A, Chase TN.
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [Abstract] [Full Text] [Related]

  • 22. [F-18 FDG PET in dementia].
    Ichiya Y.
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [Abstract] [Full Text] [Related]

  • 23. [Quantified EEG in the diagnosis of Alzheimer's type dementia].
    Gueguen B, Derouesné C, Bourdel MC, Guillou S, Landre E, Gaches J, Hossard H, Ancri D, Mann M.
    Neurophysiol Clin; 1991 Dec; 21(5-6):357-71. PubMed ID: 1808495
    [Abstract] [Full Text] [Related]

  • 24. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI.
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [Abstract] [Full Text] [Related]

  • 25. A promising method to distinguish vascular dementia from Alzheimer's disease with standardized low-resolution brain electromagnetic tomography and quantitative EEG.
    Wu L, Wu L, Chen Y, Zhou J.
    Clin EEG Neurosci; 2014 Jul; 45(3):152-7. PubMed ID: 24214287
    [Abstract] [Full Text] [Related]

  • 26. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C, Buerger K, Kalbe E, Drzezga A, Teipel SJ, Markiewicz P, Herholz K, Heiss WD, Hampel H.
    Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
    [Abstract] [Full Text] [Related]

  • 27. Quantified-EEG in normal aging and dementias.
    d'Onofrio F, Salvia S, Petretta V, Bonavita V, Rodriguez G, Tedeschi G.
    Acta Neurol Scand; 1996 May; 93(5):336-45. PubMed ID: 8800344
    [Abstract] [Full Text] [Related]

  • 28. Comparability of FDG PET studies in probable Alzheimer's disease.
    Herholz K, Perani D, Salmon E, Franck G, Fazio F, Heiss WD, Comar D.
    J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064
    [Abstract] [Full Text] [Related]

  • 29. Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status.
    Knott V, Mohr E, Mahoney C, Ilivitsky V.
    J Psychiatry Neurosci; 2001 Mar; 26(2):106-16. PubMed ID: 11291527
    [Abstract] [Full Text] [Related]

  • 30. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J, Itoh M, Matsuzawa T.
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [Abstract] [Full Text] [Related]

  • 31. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
    Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, Imbeault H, Turcotte É, Fulop T, Cunnane SC.
    J Alzheimers Dis; 2015 Oct; 43(4):1343-53. PubMed ID: 25147107
    [Abstract] [Full Text] [Related]

  • 32. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [Abstract] [Full Text] [Related]

  • 33. Positron emission tomographic studies of aging and Alzheimer disease.
    de Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodie J, Kricheff II, Wolf AP.
    AJNR Am J Neuroradiol; 1983 Nov; 4(3):568-71. PubMed ID: 6410799
    [Abstract] [Full Text] [Related]

  • 34. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 35. Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.
    Moretti DV, Pievani M, Pini L, Guerra UP, Paghera B, Frisoni GB.
    Neurobiol Aging; 2017 Oct; 58():213-224. PubMed ID: 28755648
    [Abstract] [Full Text] [Related]

  • 36. Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type.
    Chiaramonti R, Muscas GC, Paganini M, Müller TJ, Fallgatter AJ, Versari A, Strik WK.
    Neuropsychobiology; 1997 Oct; 36(3):153-8. PubMed ID: 9313246
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET.
    Murphy DG, Bottomley PA, Salerno JA, DeCarli C, Mentis MJ, Grady CL, Teichberg D, Giacometti KR, Rosenberg JM, Hardy CJ.
    Arch Gen Psychiatry; 1993 May; 50(5):341-9. PubMed ID: 8489323
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.